Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Nephron Pharmaceuticals Corp.
483
•Nephron Pharmaceuticals Corp.•February 21, 2014

Nephron Pharmaceuticals Corp. – FDA 483, Feb 21, 2014

Record Details

Nephron Pharmaceuticals Corp. in Orlando, FL, a sterile drug and device manufacturer, was cited for numerous significant deficiencies across its quality system, laboratory controls, and medical device procedures. Key issues include inadequate investigations into out-of-specification drug products, failure to submit field alert reports, and widespread lack of established or followed procedures for stability testing, labeling control, and corrective/preventive actions. The firm also failed to adequately manage and report adverse drug and device events, including a Class I recall for a choking hazard.

Company
Nephron Pharmaceuticals Corp.
Inspection date
February 21, 2014
Product type
drugs
Office
Office of Medical Device and Radiological Health Division II
People
  • Jessica L. Pressley (Pharmacy Compounding National Expert, Drug Specialist, Drug Specialist, Foreign Cadre)
  • Richard K. Vogel (Principal )
  • Paul A. Bonneau (Chef de projet)
  • Ileana Barreto-Petit
View Company Profile

ID · e406463a-7f55-4e3b-ba70-d214fe456a85

Other documents for Nephron Pharmaceuticals Corp.
  • 483 - 2015-08-14August 14, 2015
  • 483 - 2012-08-17August 17, 2012
  • 483 - 2011-06-17June 17, 2011
  • 483 - 2010-05-18May 18, 2010

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nephron Pharmaceuticals Corp.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.